Molecular Diagnostics Market Poised to Register 9.24% CAGR through 2022

 

Contact Information
Crystal Market Research
304 South Jones Blvd, Suite 1896,, Las Vegas NV 89
Las Vegas
NV - 89107
United States
+1-888-213-4282
sales@crystalmarketresearch.com
 
The global Molecular Diagnostics based on different infectious diseases are segmented into Flu, Tuberculosis, Meningitis, RSV Virus, Hepatitis B, Hepatitis C, HPV, STD, HIV, Dengue, Gonorrhea, Chlamydia, TORCH, and H. Pylori. The test location fragment incorporates PoC, central laboratories, and self-test or over-the-counter. In 2015 Central laboratories commanded this fragment with a share of more than 60 percent. The major components adding to the expansive share of this portion are high method volumes, their bigger existence in the nations that are underdeveloped, and the rising consciousness about early detection of diseases. The PoC section is anticipated to indicate lucrative development in the upcoming years. Advent of technologically inventive gadgets and the rising requirement for bedside patient monitoring are the key drivers highlighting the development of this portion. For example, the cobas product array by Roche is a PCR-based PoC framework additionally assessed to furnish this section with an exponential development platform. In 2015, the reagents section held the biggest offer producing income of around USD 3.6 billion. The reagents segment is determined to develop at a significant pace, along these lines rendering it the quickest developing section.

Competitive Insights- Molecular Diagnostics Market
Some of the leading players in the market are Novartis, Bayer, Becton Dickinson, Danaher Corporation, Roche Holding AG, Qiagen, Abbott Molecular Inc, Sysmex Corporation, Hologic, BioMerieux, Johnson & Johnson and Cepheid Inc.

Industry Outlook and Trend Analysis- Molecular Diagnostics Market
The Molecular Diagnostics Market was worth USD 2.50 billion in the year 2012 and is expected to reach approximately USD 6.05 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 9.24% during the forecast period. Molecular diagnostics are exceptionally viable in diagnosing contagious diseases and operating preventive cancer screening in this way assisting healthcare experts with prescribing precise restorative mediations in the beginning periods of sicknesses. Expanding pervasiveness of hospital procured diseases and other transferable contaminations are anticipated to drive the area extension over the conjecture time frame.

The Molecular Diagnostics Market is segmented as follows-

Molecular Diagnostics Market, By Infectious Disease, Estimates and Forecast, 2012-2022 ($Million)
Flu
Tuberculosis
Meningitis
RSV Virus
Hepatitis B
Hepatitis C
HPV
STD
HIV
Dengue
Gonorrhea
Chlamydia
TORCH
H. Pylori

Molecular Diagnostics Market, By Technology, Estimates and Forecast, 2012-2022 ($Million)
PCR
Real-Time PCR
DNA/RNA Purification

What makes our report unique?
1) An extensive research study on the Global Molecular Diagnostics market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Molecular Diagnostics market.

2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.

3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.

Major TOC of Molecular Diagnostics Market:
Part 1. Introduction
Part 2. Executive Summary
Part 3. Market Overview
Part 4. Market Analysis by Regions
Part 5. Molecular Diagnostics Market, By Application
Part 6. Molecular Diagnostics Market, By Services
Part 7. Molecular Diagnostics Market, By Product
Part 8. Molecular Diagnostics Market, By Region
Part 9. Company Profiles
Part 10. Global Molecular Diagnostics Market Competition, by Manufacturer
Part 11. Molecular Diagnostics Market Forecast (2018-2023)
…CONTINUED FOR TOC

Research Methodology:
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Enquire about Extensive Report at: https://www.crystalmarketresearch.com/send-an-enquiry/HC11353

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
For more information, visit: https://www.crystalmarketresearch.com/send-an-enquiry/HC11353


Molecular Diagnostics Market, Molecular Diagnostics Market trends, Molecular Diagnostics Market Share, Global Molecular Diagnostics Industry Analysis, Molecular Diagnostics Market Research, Molecular Diagnostics Market Forecast, Global Molecular Diagnosti

 

If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.